Looks like the backended deal is here! Glad I got back in at an average of $1.50 after bailing out two years ago when this was over $2.00 but racing south as everyone wanted instant gratification ... I see Morningstar have upgraded their current valuation to 2.44 on Friday from 1.70 ish....
https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/2770-0P00006Y3T-20210813/pdf?access_token=0007yOFqc5rdMsTB7WapOkxf1Pex
I think the science will come through on this - not one hint of any mal side effects in any of the testing to date.
The originally scientist who founded Trofinetide has been Knighted - Margaret Brimble
https://returnonscience.co.nz/margaret-brimble
80% plus chance of success in phase 3 for Retts. I think it is closer to 99% chance of success.
We were at over $3.50 two years (or more ago) in the lead up to the Acadia deal - I think we are heading back to $3.50 plus again before the announcement regarding phase 3 later this year and if that succeeds then we can hope to worth over $5.00 per share.... at least.
People should put their trust in this science and buy Neuren now!
imho
Updated MST report - target of $3.68 a share, page-106
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 696 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.67 | 6942 | 8 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |